These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27244899)

  • 61. Association study of the PLXNA4 gene with the risk of Alzheimer's disease.
    Wang H; Sun FR; Tan L; Wang HF; Zhang W; Wang ZX; Jiang T; Yu JT; Tan L
    Ann Transl Med; 2016 Mar; 4(6):108. PubMed ID: 27127761
    [TBL] [Abstract][Full Text] [Related]  

  • 62. DAPK1 variants are associated with Alzheimer's disease and allele-specific expression.
    Li Y; Grupe A; Rowland C; Nowotny P; Kauwe JS; Smemo S; Hinrichs A; Tacey K; Toombs TA; Kwok S; Catanese J; White TJ; Maxwell TJ; Hollingworth P; Abraham R; Rubinsztein DC; Brayne C; Wavrant-De Vrièze F; Hardy J; O'Donovan M; Lovestone S; Morris JC; Thal LJ; Owen M; Williams J; Goate A
    Hum Mol Genet; 2006 Sep; 15(17):2560-8. PubMed ID: 16847012
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of ADAM10 Polymorphisms on Plasma Level of Soluble Receptor for Advanced Glycation End Products and The Association With Alzheimer's Disease Risk.
    Huang WH; Chen W; Jiang LY; Yang YX; Yao LF; Li KS
    Front Genet; 2018; 9():540. PubMed ID: 30555509
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease.
    Lacher SE; Alazizi A; Wang X; Bell DA; Pique-Regi R; Luca F; Slattery M
    Redox Biol; 2018 Apr; 14():686-693. PubMed ID: 29179108
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association and heterogeneity at the GAPDH locus in Alzheimer's disease.
    Allen M; Cox C; Belbin O; Ma L; Bisceglio GD; Wilcox SL; Howell CC; Hunter TA; Culley O; Walker LP; Carrasquillo MM; Dickson DW; Petersen RC; Graff-Radford NR; Younkin SG; Ertekin-Taner N
    Neurobiol Aging; 2012 Jan; 33(1):203.e25-33. PubMed ID: 20864222
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association study of CREB1 and CBP genes with Alzheimer's disease in Han Chinese.
    Tang W; Yang F; Lu W; Ni J; Zhang J; Tang W; Tang W; Zhang C
    Asia Pac Psychiatry; 2017 Sep; 9(3):. PubMed ID: 28856841
    [No Abstract]   [Full Text] [Related]  

  • 67. Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysis.
    Webster J; Reiman EM; Zismann VL; Joshipura KD; Pearson JV; Hu-Lince D; Huentelman MJ; Craig DW; Coon KD; Beach T; Rohrer KC; Zhao AS; Leung D; Bryden L; Marlowe L; Kaleem M; Mastroeni D; Grover A; Rogers J; Heun R; Jessen F; Kölsch H; Heward CB; Ravid R; Hutton ML; Melquist S; Petersen RC; Caselli RJ; Papassotiropoulos A; Stephan DA; Hardy J; Myers A
    Int J Mol Epidemiol Genet; 2010; 1(1):19-30. PubMed ID: 21537449
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Analysis of Genome-Wide Association Study (GWAS) data looking for replicating signals in Alzheimer's disease (AD).
    Shi H; Medway C; Bullock J; Brown K; Kalsheker N; Morgan K
    Int J Mol Epidemiol Genet; 2010; 1(1):53-66. PubMed ID: 21537453
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Smoking and Alzheimer's disease among Mongolian and Han Chinese aged 55 years and over living in the Inner Mongolia farming area of China.
    Zhang C; Da L; Zhao S; Wang D; Niu G; Huriletemuer
    Neural Regen Res; 2012 Jul; 7(20):1570-7. PubMed ID: 25657695
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SNP rs657152 Is Not Associated with the Level of Viral Load in COVID-19 or the Probability of Disease in the Population of Caucasians in Eastern Siberia.
    Orlova EA; Ogarkov OB; Khromova PA; Sinkov VV; Khasnatinov MA; Zhdanova SN; Rychkova LV; Kolesnikova LI
    Russ J Genet; 2021; 57(8):982-984. PubMed ID: 34483600
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Correction to: Alzheimer's genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner.
    Eysert F; Coulon A; Boscher E; Vreulx AC; Flaig A; Mendes T; Hughes S; Grenier-Boley B; Hanoulle X; Demiautte F; Bauer C; Marttinen M; Takalo M; Amouyel P; Desai S; Pike I; Hiltunen M; Chécler F; Farinelli M; Delay C; Malmanche N; Hébert SS; Dumont J; Kilinc D; Lambert JC; Chapuis J
    Mol Psychiatry; 2021 Oct; 26(10):5608. PubMed ID: 33398090
    [No Abstract]   [Full Text] [Related]  

  • 72. Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Xiao T; Jiao B; Zhang W; Tang B; Shen L
    CNS Drugs; 2016 Oct; 30(10):899-907. PubMed ID: 27282366
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Meta-analysis of risk factors for Parkinson's disease dementia.
    Xu Y; Yang J; Shang H
    Transl Neurodegener; 2016; 5():11. PubMed ID: 27257478
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MEF2C rs190982 polymorphism with late-onset Alzheimer's disease in Han Chinese: A replication study and meta-analyses.
    Tang SS; Wang HF; Zhang W; Kong LL; Zheng ZJ; Tan MS; Tan CC; Wang ZX; Tan L; Jiang T; Yu JT; Tan L
    Oncotarget; 2016 Jun; 7(26):39136-39142. PubMed ID: 27276684
    [TBL] [Abstract][Full Text] [Related]  

  • 75. INPP5D rs35349669 polymorphism with late-onset Alzheimer's disease: A replication study and meta-analysis.
    Jing H; Zhu JX; Wang HF; Zhang W; Zheng ZJ; Kong LL; Tan CC; Wang ZX; Tan L; Tan L
    Oncotarget; 2016 Oct; 7(43):69225-69230. PubMed ID: 27750211
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism.
    Chapuis J; Flaig A; Grenier-Boley B; Eysert F; Pottiez V; Deloison G; Vandeputte A; Ayral AM; Mendes T; Desai S; Goate AM; Kauwe JSK; Leroux F; Herledan A; Demiautte F; Bauer C; Checler F; Petersen RC; Blennow K; Zetterberg H; Minthon L; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Albert M; Moghekar A; O'Brien R; Peskind ER; Malmanche N; Schellenberg GD; Dourlen P; Song OR; Cruchaga C; Amouyel P; Deprez B; Brodin P; Lambert JC;
    Acta Neuropathol; 2017 Jun; 133(6):955-966. PubMed ID: 27933404
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interpretation of risk loci from genome-wide association studies of Alzheimer's disease.
    Andrews SJ; Fulton-Howard B; Goate A
    Lancet Neurol; 2020 Apr; 19(4):326-335. PubMed ID: 31986256
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genetics of Alzheimer's Disease.
    Kim JH
    Dement Neurocogn Disord; 2018 Dec; 17(4):131-136. PubMed ID: 30906402
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The relationship of early- and late-onset Alzheimer's disease genes with COVID-19.
    Sirin S; Nigdelioglu Dolanbay S; Aslim B
    J Neural Transm (Vienna); 2022 Jul; 129(7):847-859. PubMed ID: 35429259
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genetic Association of FERMT2, HLA-DRB1, CD2AP, and PTK2B Polymorphisms With Alzheimer's Disease Risk in the Southern Chinese Population.
    Yan Y; Zhao A; Qui Y; Li Y; Yan R; Wang Y; Xu W; Deng Y
    Front Aging Neurosci; 2020; 12():16. PubMed ID: 32116649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.